Levonantradol
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171849This classification denotes an antiemetic agent with the molecular formula C27H35NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03S640ADSK, chemically known as 1,9-phenanthridinediol, 5,6,6a,7,8,9,10,10a-octahydro-6-methyl-3-((1r)-1-methyl-4-phenylbutoxy)-, 1-acetate, (6s,6ar,9r,10ar)- but generally known as levonantradol, which bears US NIH Compound Identifier 5361881. European Medicines Agency schedules Levonantradol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08482MIG. The term LEVONANTRADOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). LEVONANTRADOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levonantradol under HS 29339990 and SITC 51577. As of Q4 2014, LEVONANTRADOL remains the US FDA Preferred Term for this commodity. Levonantradol bears US NLM identifiers UMLS ID C0125660 and NCI Concept Code C1385. SMILES: OC1CC2C(CC1)C(NC1C2C(OC(=O)C)CC(OC(CCCC2CCCCC2)C)C1)C.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.